antiarrhythmic

(redirected from Antiarrhythmic agent)
Also found in: Dictionary, Thesaurus, Medical, Legal, Financial, Wikipedia.

antiarrhythmic

[‚an·tē‚ā′rith·mik]
(medicine)
An agent that prevents or alleviates cardiac arrhythmia.
References in periodicals archive ?
Amiodarone, as a Class III antiarrhythmic agent, can prolong the effective refractory period of myocardial cells, shorten the interval between action potentials, decelerate conduction and terminate reentrant excitation by non-competitively binding a- and b-adrenergic receptors on the myocardial cell membrane.
Both Class IA (quinidine) and class III (sotalol) antiarrhythmic agents prolong action potential duration by blocking outward potassium current and cause TdP in a small percentage of patients who are on these drugs.
It offers clinicians a unique, ready-to-use antiarrhythmic agent for critical and time-sensitive situations, while also providing convenience to caregivers and value to pharmacists," said Robert M.
Dronedarone (Multaq, X) is an antiarrhythmic agent that is indicated for patients with atrial fibrillation or atrial flutter.
Clinical efficacy of amiodarone as an antiarrhythmic agent.
The company said that the antiarrhythmic agent Amiodarone HCl Injection is now available in an improved prefilled plastic syringe that is compatible with most standard I.
ORLANDO -- The novel multi-channel-blocking antiarrhythmic agent dronedarone cut the risk of cardiovascular hospitalization or all-cause mortality by 24% in a meta-analysis of five placebo-controlled, randomized trials involving 6,157 patients with atrial fibrillation or atrial flutter.
Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction.
Patients can be given adenosine (Adenocard), which is a fast-acting intravenous (IV) antiarrhythmic agent that can offer faster activation if given by IV.
Early clinical trials suggested that PAF could be suppressed by ARB therapy, particularly when combined with an antiarrhythmic agent.
In this multicenter Dutch study, 206 patients with persistent atrial fibrillation (AF) underwent cardioversion followed by a loading dose of amiodarone at 600 mg/day for 4 weeks and were then randomized to continuation of the antiarrhythmic agent at 200 mg/day or discontinuation of amiodarone.